Development of Coagulation Factor XII Antibodies for Inhibiting Vascular Device-Related Thrombosis

INTRODUCTION: Vascular devices such as stents, hemodialyzers, and membrane oxygenators can activate blood coagulation and often require the use of systemic anticoagulants to selectively prevent intravascular thrombotic/embolic events or extracorporeal device failure. Coagulation factor (F)XII of the...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cell Mol Bioeng
Asıl Yazarlar: Kohs, T. C. L., Lorentz, C. U., Johnson, J., Puy, C., Olson, S. R., Shatzel, J. J., Gailani, D., Hinds, M. T., Tucker, E. I., Gruber, A., McCarty, O. J. T., Wallisch, M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer International Publishing 2020
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8010086/
https://ncbi.nlm.nih.gov/pubmed/33868498
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12195-020-00657-6
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller